| Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations R Jandoc, AM Burden, M Mamdani, LE Lévesque, SM Cadarette Journal of clinical epidemiology 68 (8), 950-956, 2015 | 409 | 2015 |
| Bone fragility in diabetes: novel concepts and clinical implications LC Hofbauer, B Busse, R Eastell, S Ferrari, M Frost, R Müller, AM Burden, ... The Lancet Diabetes & Endocrinology 10 (3), 207-220, 2022 | 157 | 2022 |
| Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study J van Dalem, MCGJ Brouwers, CDA Stehouwer, A Krings, HGM Leufkens, ... bmj 354, 2016 | 121 | 2016 |
| Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts OA Oshagbemi, AM Burden, DCW Braeken, Y Henskens, EFM Wouters, ... American journal of respiratory and critical care medicine 195 (10), 1402-1404, 2017 | 108 | 2017 |
| The impact of pharmacist interventions on osteoporosis management: a systematic review MN Elias, AM Burden, SM Cadarette Osteoporosis international 22, 2587-2596, 2011 | 83 | 2011 |
| Case‐crossover study design in pharmacoepidemiology: systematic review and recommendations GP Consiglio, AM Burden, M Maclure, L McCarthy, SM Cadarette Pharmacoepidemiology and drug safety 22 (11), 1146-1153, 2013 | 71 | 2013 |
| Use of glucagon-like-peptide 1 receptor agonists and risk of fracture as compared to use of other anti-hyperglycemic drugs JHM Driessen, HAW van Onzenoort, J Starup-Linde, R Henry, AM Burden, ... Calcified tissue international 97, 506-515, 2015 | 68 | 2015 |
| Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis JHM Driessen, RMA Henry, HAW van Onzenoort, A Lalmohamed, ... Calcified tissue international 97, 104-112, 2015 | 67 | 2015 |
| Measuring and improving adherence to osteoporosis pharmacotherapy SM Cadarette, AM Burden Current opinion in rheumatology 22 (4), 397-403, 2010 | 63 | 2010 |
| Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada AM Burden, JM Paterson, DH Solomon, M Mamdani, DN Juurlink, ... Osteoporosis international 23, 1075-1082, 2012 | 58 | 2012 |
| Long-term persistence with anti-osteoporosis drugs after fracture C Klop, PMJ Welsing, PJM Elders, JA Overbeek, PC Souverein, ... Osteoporosis International 26, 1831-1840, 2015 | 57 | 2015 |
| Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study MA Amiche, S Abtahi, JHM Driessen, P Vestergaard, F de Vries, ... Archives of Osteoporosis 13, 1-10, 2018 | 54 | 2018 |
| RETRACTED ARTICLE: Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010 S Abtahi, JHM Driessen, P Vestergaard, J van den Bergh, A Boonen, ... Archives of osteoporosis 13, 1-7, 2018 | 46 | 2018 |
| Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD) LEJM Scheepers, AM Burden, ICW Arts, B Spaetgens, P Souverein, ... Rheumatology 57 (9), 1641-1650, 2018 | 44 | 2018 |
| Thromboembolic safety reporting of tofacitinib and baricitinib: an analysis of the WHO VigiBase E Vallejo-Yagüe, S Weiler, R Micheroli, AM Burden Drug safety 43, 881-891, 2020 | 42 | 2020 |
| Cardiovascular safety profile of romosozumab: a pharmacovigilance analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) A Vestergaard Kvist, J Faruque, E Vallejo-Yagüe, S Weiler, EM Winter, ... Journal of Clinical Medicine 10 (8), 1660, 2021 | 35 | 2021 |
| Duration of bisphosphonate drug holidays in osteoporosis patients: a narrative review of the evidence and considerations for decision-making KN Hayes, EM Winter, SM Cadarette, AM Burden Journal of Clinical Medicine 10 (5), 1140, 2021 | 32 | 2021 |
| Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK RGPJ de Jong, PJHL Peeters, AM Burden, ML de Bruin, HR Haak, ... Cancer epidemiology 54, 104-111, 2018 | 32 | 2018 |
| Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data AM Burden, JM Paterson, A Gruneir, SM Cadarette pharmacoepidemiology and drug safety 24 (1), 67-74, 2015 | 32 | 2015 |
| No decreased risk of gastrointestinal cancers in users of metformin in The Netherlands; a time-varying analysis of metformin exposure RG de Jong, AM Burden, S de Kort, MP van Herk-Sukel, PA Vissers, ... Cancer Prevention Research 10 (5), 290-297, 2017 | 30 | 2017 |
Frank de VriesProfessor Emeritus, The NetherlandsVerified email at fdevries.com
